...
首页> 外文期刊>The American journal of hospice & palliative medicine >Role of Early Palliative Care Interventions in Hematological Malignancies and Bone Marrow Transplant Patients: Barriers and Potential Solutions
【24h】

Role of Early Palliative Care Interventions in Hematological Malignancies and Bone Marrow Transplant Patients: Barriers and Potential Solutions

机译:早期姑息治疗干预在血液恶性肿瘤和骨髓移植患者中的作用:障碍和潜在解决方案

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Despite advances in palliative care management of physical, psychological, and emotional symptoms along the spectrum of chronic conditions, early palliative care interventions are not used frequently and comprehensively in bone marrow transplant units. Methods: The literature review of PubMed articles in English published until December 2017. Results: Patients with hematologic malignancies and bone marrow transplant interventions are a heterogeneous group. The majority experience symptoms associated with induction or condition regimens. Curative intent of treatment is the norm. Pain, mucositis, nausea and vomiting, diarrhea, psychological, spiritual, and emotional concerns may not be properly and comprehensively tackled by primary oncology and bone marrow transplant teams. Quality of life may be decreased due to the presence of these symptoms. Obstacles to early palliative care interventions include overestimation of survival, focus on curative intent with underestimation of palliative care needs, lack of a comprehensive understanding of hematologic malignancies and bone marrow transplant process on the side of palliative care providers, and logistical restrictions. Potential interventions include education of oncologists, palliative care providers, patients, integration of models of care pre- and posttreatment and bone marrow transplantation, development of guidelines, institutional commitment and leadership in creating new initiatives, clinical research activities to measure outcomes, and community-based participatory research. Conclusions: Early palliative care interventions are beneficial for patients with hematologic malignancies and bone marrow transplant processes. Better understanding of barriers to its implementation and development of creative initiatives is of paramount importance. New research endeavors should focus on providers' attitudes toward patients and communities.
机译:介绍:尽管跨慢性条件谱的体外,心理和情绪症状的姑息治疗管理进展,但早期的姑息治疗干预措施不会经常和全面地使用骨髓移植单位。方法:在2017年12月到12月的英语中发布的PubMed文章的文献综述。结果:血液学恶性肿瘤和骨髓移植干预患者是异质组。大多数经历与诱导或条件方案相关的症状。治疗的治疗意图是常态。疼痛,粘膜炎,恶心和呕吐,腹泻,心理,精神和情绪问题可能无法通过原发性肿瘤和骨髓移植团队妥善解决。由于这些症状存在,寿命的质量可能会降低。早期姑息治疗干预的障碍包括高估生存,重点关注低估姑息治疗需求的疗效意图,缺乏对姑息治疗提供者一侧的血液学恶性肿瘤和骨髓移植过程以及后勤限制。潜在的干预包括肿瘤科学家,姑息治疗提供者,患者,护理模型和骨髓移植的融合,制定新举措,临床研究活动,衡量结果的临床研究活动以及社区的临床研究活动的发展基于参与式研究。结论:早期姑息治疗干预措施对血液学恶性肿瘤和骨髓移植过程的患者有益。更好地了解其实现和发展创造性举措的障碍是至关重要的。新的研究努力应专注于提供者对患者和社区的态度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号